<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Endometriosis & Adenomyosis: The Inflammatory Profile | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}

.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}

.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CHECK UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 list-style: none;
 padding-left: 0;
}

.takeaways-box li {
 margin-bottom: 12px;
 position: relative;
 padding-left: 28px;
}

.takeaways-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #B8860B;
 font-weight: 800;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 margin-bottom: 8px;
 color: #475569;
}

.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.stat-highlight {
 font-weight: 800;
 color: #722F37;
}

 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 27: Specialty Applications</span>
 <h1 class="lesson-title">Endometriosis & Adenomyosis: The Inflammatory Profile</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">üí° Lesson 5 of 8</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Credential Verification</div>
 <div class="title">AccrediPro Standards Institute ‚Ä¢ Advanced Clinical Specialty</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#silent-endo"><span class="section-num">01</span>The Silent Endo Phenomenon</a></li>
 <li><a href="#functional-assessment"><span class="section-num">02</span>Functional Assessment & Markers</a></li>
 <li><a href="#integrative-advocacy"><span class="section-num">03</span>Excision vs. Suppression</a></li>
 <li><a href="#endo-diet"><span class="section-num">04</span>The 'Endo-Diet' Framework</a></li>
 <li><a href="#resilience"><span class="section-num">05</span>Emotional Resilience</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p><strong>Module Connection:</strong> While previous lessons focused on metabolic phenotypes like PCOS, we now pivot to the <strong>immunological and inflammatory landscape</strong> of Endometriosis and Adenomyosis‚Äîconditions where the pelvic environment itself becomes hostile to conception.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>Welcome, Practitioner. Endometriosis affects approximately <span class="stat-highlight">1 in 10 women</span> of reproductive age, yet it remains one of the most mismanaged conditions in the fertility space. As a Certified Fertility Coach‚Ñ¢, your role isn't just to suggest "anti-inflammatory foods," but to understand the <strong>molecular crosstalk</strong> between estrogen and the immune system that drives these conditions. Today, we move beyond "bad periods" into the clinical reality of the inflammatory profile.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze the mechanism of 'Silent Endo' and its specific impact on the implantation window.</li>
 <li>Identify functional markers of systemic inflammation, including hs-CRP and the estrogen dominance feedback loop.</li>
 <li>Evaluate the clinical pros and cons of laparoscopic excision versus medical suppression (GnRH agonists).</li>
 <li>Design a targeted nutrition protocol focused on prostaglandin balance and Phase II liver detoxification.</li>
 <li>Apply emotional resilience frameworks to support clients through chronic pain and diagnostic delays.</li>
 </ul>
 </div>

 <h2 id="silent-endo">The 'Silent Endo' Phenomenon</h2>
 <p>In conventional medicine, Endometriosis is often synonymous with <em>dysmenorrhea</em> (painful periods). However, in the fertility clinic, we frequently encounter <span class="highlight">"Silent Endo"</span>‚Äîpatients with stage III or IV endometriosis who have never experienced significant pelvic pain. This creates a dangerous diagnostic gap.</p>
 
 <p>Silent Endo impacts fertility through three primary mechanisms:</p>
 <ul>
 <li><strong>Toxic Peritoneal Fluid:</strong> The inflammatory cytokines (like TNF-Œ± and IL-6) in the pelvic cavity can be "sperm-toxic," damaging sperm before they reach the egg.</li>
 <li><strong>Progesterone Resistance:</strong> Endometriotic lesions lack the proper receptors to respond to progesterone, leading to a "luteal phase defect" at the cellular level even when serum progesterone levels look normal.</li>
 <li><strong>Impaired Tubal Motility:</strong> Micro-adhesions, invisible on ultrasound, can prevent the fallopian tubes from effectively "picking up" the egg during ovulation.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Identifying the "Silent" Client</span>
 <p>If a client has "unexplained infertility" and has failed 2+ high-quality embryo transfers (IVF), advocate for an <strong>EndomeTRIO</strong> or <strong>ReceptivaDx</strong> test. These look for BCL6, a marker of uterine inflammation highly correlated with silent endometriosis.</p>
 </div>

 <!-- Case Study 1 -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üë§</div>
 <div>
 <p class="title">Case Study: Elena, 41</p>
 <p class="subtitle">Teacher ‚Ä¢ Secondary Infertility ‚Ä¢ High-Stress Profile</p>
 </div>
 </div>
 <div class="case-study-content">
 <p><strong>Presenting Symptoms:</strong> Elena presented with secondary infertility after 18 months of trying. She reported "mild" periods but complained of significant bloating (Endo-belly) and mid-cycle spotting. Her conventional OBGYN dismissed her concerns because her AMH was "good for her age."</p>
 <p><strong>Intervention:</strong> We utilized the <strong>F.E.R.T.I.L.E. Method‚Ñ¢</strong> to map her symptoms. Functional testing revealed an <strong>hs-CRP of 4.2 mg/L</strong> (optimal is &lt;1.0) and severe estrogen dominance on a DUTCH test. We coached her to request a specialist referral for a diagnostic laparoscopy.</p>
 <p><strong>Outcome:</strong> Stage II Endometriosis was found and excised. Following 3 months of an anti-inflammatory protocol, her hs-CRP dropped to 0.8 mg/L. She conceived naturally the following cycle.</p>
 </div>
 </div>

 <h2 id="functional-assessment">Functional Assessment: The Inflammatory Profile</h2>
 <p>To coach effectively, you must understand that Endometriosis is an <strong>estrogen-dependent inflammatory disease</strong>. The lesions actually produce their own estrogen via the enzyme <em>aromatase</em>, creating a self-perpetuating loop of growth and inflammation.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Marker</th>
 <th>Conventional Range</th>
 <th>Functional Fertility Range</th>
 <th>Significance</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>hs-CRP</strong></td>
 <td>&lt; 3.0 mg/L</td>
 <td><strong>&lt; 1.0 mg/L</strong></td>
 <td>General systemic inflammation; high levels correlate with implantation failure.</td>
 </tr>
 <tr>
 <td><strong>CA-125</strong></td>
 <td>&lt; 35 U/mL</td>
 <td><strong>Trend Analysis</strong></td>
 <td>While not diagnostic, a rise from baseline often indicates an endo flare.</td>
 </tr>
 <tr>
 <td><strong>Ferritin</strong></td>
 <td>15 - 150 ng/mL</td>
 <td><strong>50 - 90 ng/mL</strong></td>
 <td>Low ferritin is common due to heavy bleeding; high ferritin may indicate acute inflammation.</td>
 </tr>
 <tr>
 <td><strong>2:16 Hydroxyestrone Ratio</strong></td>
 <td>Not Tested</td>
 <td><strong>&gt; 2.0</strong></td>
 <td>Indicates the body is favoring the "protective" estrogen pathway over the "pro-inflammatory" 16-OH pathway.</td>
 </tr>
 </tbody>
 </table>

 <h2 id="integrative-advocacy">Integrative Advocacy: Excision vs. Suppression</h2>
 <p>Your clients will often be presented with two medical paths. Your role is to help them navigate this decision without overstepping your scope.</p>
 
 <h3>1. Laparoscopic Excision (The Gold Standard)</h3>
 <p>This involves surgically cutting out the lesions. Unlike "ablation" (burning the surface), excision removes the root of the lesion. This is generally preferred for fertility as it restores pelvic anatomy.</p>
 
 <h3>2. Medical Suppression (GnRH Agonists/Antagonists)</h3>
 <p>Drugs like Lupron or Orilissa put the body into a temporary "chemical menopause." This starves the lesions of estrogen. While effective at reducing inflammation before an IVF transfer, it does not remove existing adhesions or scar tissue.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The "IVF Prep" Strategy</span>
 <p>Many top-tier clinics now use 2 months of Lupron Depot prior to an embryo transfer for endo patients. This "calms" the uterine environment. As a coach, this is the time to focus heavily on <strong>mitochondrial support</strong> and <strong>bone density nutrition</strong> (calcium/K2), as these meds can deplete minerals.</p>
 </div>

 <h2 id="endo-diet">Targeted Nutrition: The 'Endo-Diet' Framework</h2>
 <p>The goal of nutrition for Endometriosis and Adenomyosis is twofold: <span class="highlight">Prostaglandin Modulation</span> and <span class="highlight">Estrogen Clearance</span>.</p>

 <h3>Prostaglandin Balance</h3>
 <p>Prostaglandins are hormone-like substances that mediate pain and uterine contractions. <strong>PGE2</strong> is pro-inflammatory, while <strong>PGE1 and PGE3</strong> are anti-inflammatory. We optimize this through:</p>
 <ul>
 <li><strong>High-Dose Omega-3s:</strong> Aiming for 2-3g of combined EPA/DHA to shift the body away from PGE2 production.</li>
 <li><strong>Eliminating A1 Dairy:</strong> The protein <em>casein A1</em> can trigger inflammatory responses in the gut that exacerbate pelvic pain.</li>
 </ul>

 <h3>Phase II Liver Detoxification</h3>
 <p>If the liver cannot clear used estrogen, it recirculates, feeding the endo lesions. We support this via:</p>
 <ul>
 <li><strong>Cruciferous Vegetables:</strong> Broccoli sprouts, cauliflower, and kale contain <em>Indole-3-Carbinol</em> (I3C) and <em>Sulforaphane</em>.</li>
 <li><strong>Calcium D-Glucarate:</strong> A supplement that prevents the "un-zipping" of estrogen in the gut (inhibiting the beta-glucuronidase enzyme).</li>
 </ul>

 <h2 id="resilience">Emotional Resilience: Validating the Invisible</h2>
 <p>The average time to diagnose Endometriosis is <span class="stat-highlight">7 to 10 years</span>. By the time a client reaches you, they have likely been gaslit by multiple medical professionals. They are often "hyper-vigilant" regarding their bodily sensations.</p>
 
 <p><strong>The Resilience Strategy:</strong> Use "Somatic Tracking." Instead of fearing the pain, teach the client to observe it with curiosity. This reduces the amygdala's "threat" response, which can actually lower the perceived intensity of the pain. Validating that their pain is <em>biochemical</em>, not <em>psychological</em>, is the first step in their emotional healing.</p>

 <div class="coach-tip">
 <span class="tip-label">Practice Management Tip</span>
 <p>Expert Fertility Coaches specializing in Endometriosis often command premium rates. A 4-month "Endo-Optimization" package can range from <strong>$2,500 to $4,500</strong>, reflecting the high level of clinical advocacy and specialized nutritional knowledge required.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why is BCL6 testing (ReceptivaDx) relevant for a client with "unexplained" IVF failure and no period pain?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">BCL6 is a marker for uterine lining inflammation. High levels are strongly associated with "Silent Endometriosis," which can cause implantation failure even in the absence of traditional symptoms like pelvic pain.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the primary functional difference between laparoscopic "ablation" and "excision"?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Ablation only burns the surface of the lesion, often leaving the "root" behind, leading to high recurrence rates. Excision surgically removes the entire lesion, including the deep tissue, and is the gold standard for fertility restoration.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. How does the enzyme aromatase contribute to the Endometriosis feedback loop?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Endometriotic lesions contain aromatase, which allows them to produce their own estrogen locally. This estrogen then triggers more inflammation, which in turn stimulates more aromatase activity, creating a self-perpetuating cycle of growth.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Which nutritional supplement specifically targets the gut enzyme beta-glucuronidase to help clear estrogen?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Calcium D-Glucarate. It inhibits beta-glucuronidase, preventing it from de-conjugating estrogen in the large intestine, ensuring the estrogen is successfully excreted in the stool rather than reabsorbed.</div>
 </div>
 </div>

 <!-- Takeaways Box -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Endometriosis is a systemic inflammatory disease, not just a localized period problem.</li>
 <li>"Silent Endo" must be ruled out in cases of recurrent implantation failure or unexplained infertility.</li>
 <li>Functional markers like hs-CRP provide a "window" into the pelvic environment that standard ultrasounds often miss.</li>
 <li>Nutrition must focus on shifting the prostaglandin balance from pro-inflammatory (PGE2) to anti-inflammatory (PGE1/3).</li>
 <li>Integrative advocacy involves helping clients choose between surgical excision and medical suppression based on their unique fertility timeline.</li>
 </ul>
 </div>

 <!-- References Box -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Bulun, S. E., et al. (2019). "Endometriosis." <em>New England Journal of Medicine</em>.</li>
 <li>Lessey, B. A., & Young, S. L. (2019). "What's new in endometriosis: the role of BCL6 and SIRT1 in infertility." <em>Fertility and Sterility</em>.</li>
 <li>Parasar, P., et al. (2017). "Endometriosis: Epidemiology, Diagnosis and Clinical Management." <em>Current Obstetrics and Gynecology Reports</em>.</li>
 <li>Nirgianakis, K., et al. (2022). "Effectiveness of Dietary Interventions in the Treatment of Endometriosis: A Systematic Review." <em>Reproductive Sciences</em>.</li>
 <li>Taylor, H. S., et al. (2021). "Endometriosis is a systemic disease, not just a disease of the pelvis." <em>American Journal of Obstetrics and Gynecology</em>.</li>
 <li>Vercellini, P., et al. (2014). "Endometriosis: current and future medical therapies." <em>Best Practice & Research Clinical Obstetrics & Gynaecology</em>.</li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>

</body>
</html>